Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,115.28
(
0.73%
)
US TECH 100
25,987.20
(
0.83%
)
Dow Jones
49,539.47
(
0.19%
)
Brent Oil
95.84
(
0.87%
)
Bitcoin
78,878.85
(
3.34%
)
News Focus
News Focus
Post# of 257435
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

EyeGuy

Send PM Follow Ignore
Followers 0
Posts 40
Boards Moderated 0
Alias Born 03/07/2006

EyeGuy

Re: DewDiligence post# 41354

Friday, 02/02/2007 2:23:57 PM

Friday, February 02, 2007 2:23:57 PM

Post# of 257435
The company's assertion that "ATG3 is the first non-invasive eye drop therapy for AMD that has entered the clinic..." is not completely true.

See http://www.othera.com/pdfs/Othera_NEI_Dry_AMD_Study.pdf
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today